'Vyvuz Capsule' can inhibit virus replication, claims Atrimed Pharma
he capsule is known to be safe, Vyvuz has ingredients that have been tested in the Government of India, Biotechnology labs
Bengaluru: A Bengaluru-headquartered plant-based medication company, Atrimed Pharmaceuticals, launched 'Vyvuz Capsule' that inhibits the COVID-19 virus by 99.9 per cent.
Addressing a press conference here on Friday, Dr Hrishikesh Damle, Founder and CEO of Atrimed Pharmaceuticals Pvt Ltd, said that along with vaccines, medicines play a major role in preventing replication of the virus.
The capsule is known to be safe, Vyvuz has ingredients that have been tested in the Government of India, Biotechnology labs and have been shown to inhibit the virus by up to 99.9 per cent.
" Vyvuz Capsule is a welcome alternative, the formulation has been tested against 'Delta' variant and was found to be effective, said Dr Damle.
The chemical formulation of the capsule is made using plant extracts of medicinal plants traditionally used in ayurveda like Centella asiatica (Muthil), Withania somnifera (Ashwagantha) and Andrographis paniculata (Kiriyatha).